PDB Short entry for 1OYH HEADER BLOOD CLOTTING 04-APR-03 1OYH TITLE CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN CAVEAT 1OYH NAG C 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: I; COMPND 4 SYNONYM: ATIII; PRO0309; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: E381A MUTANT ON THE BETA GLYCOFORM BACKGROUND OF COMPND 8 S137A; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ANTITHROMBIN-III; COMPND 11 CHAIN: L; COMPND 12 SYNONYM: ATIII; PRO0309; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: BETA GLYCOFORM SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: PLASMA; SOURCE 7 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 10 EXPRESSION_SYSTEM_CELL: BABY HAMPSTER KIDNEY CELLS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMASTOP; SOURCE 13 OTHER_DETAILS: PLASMA ALPHA ANTITHROMBIN WAS CONVERTED TO LATENT BY SOURCE 14 THE GLYCEROL METHOD, AND IS CHAIN L; SOURCE 15 MOL_ID: 2; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 ORGAN: BLOOD; SOURCE 20 TISSUE: PLASMA; SOURCE 21 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 22 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 24 EXPRESSION_SYSTEM_CELL: BABY HAMPSTER KIDNEY CELLS; SOURCE 25 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 26 EXPRESSION_SYSTEM_PLASMID: PMASTOP; SOURCE 27 OTHER_DETAILS: PLASMA ALPHA ANTITHROMBIN WAS CONVERTED TO LATENT BY SOURCE 28 THE GLYCEROL METHOD, AND IS CHAIN L KEYWDS THROMBIN; INHIBITION; HEPARIN ANALOGUE; SERINE PROTEASE INHIBITOR, KEYWDS 2 BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR D.J.D.JOHNSON,J.A.HUNTINGTON REVDAT 7 16-AUG-23 1OYH 1 REMARK REVDAT 6 27-OCT-21 1OYH 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1OYH 1 CAVEAT COMPND REMARK HET REVDAT 5 2 1 HETNAM FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 11-OCT-17 1OYH 1 REMARK REVDAT 3 13-JUL-11 1OYH 1 VERSN REVDAT 2 24-FEB-09 1OYH 1 VERSN REVDAT 1 13-APR-04 1OYH 0 JRNL AUTH D.J.D.JOHNSON,J.A.HUNTINGTON JRNL TITL THE INFLUENCE OF HINGE REGION RESIDUE GLU-381 ON JRNL TITL 2 ANTITHROMBIN ALLOSTERY AND METASTABILITY JRNL REF J.BIOL.CHEM. V. 279 4913 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14623882 JRNL DOI 10.1074/JBC.M311644200 REMARK 2 REMARK 2 RESOLUTION. 2.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 34900 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SAME AS 1E04 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1726 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.62 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3420 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 234 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6434 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 173 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 76.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.73000 REMARK 3 B22 (A**2) : 20.00000 REMARK 3 B33 (A**2) : -9.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -7.66000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.46 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.50 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED MLF TARGET REMARK 4 REMARK 4 1OYH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000018801. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35267 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620 REMARK 200 RESOLUTION RANGE LOW (A) : 39.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : 0.06700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.49600 REMARK 200 R SYM FOR SHELL (I) : 0.45300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1E04 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA/K PHOSPHATE, PEG 4000, PH 6.7, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.28650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 39 REMARK 465 LYS I 432 REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 GLU L 27 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 GLU L 34 REMARK 465 GLY L 35 REMARK 465 SER L 36 REMARK 465 GLU L 37 REMARK 465 GLN L 38 REMARK 465 LYS L 39 REMARK 465 ILE L 40 REMARK 465 PRO L 41 REMARK 465 ASN L 398 REMARK 465 VAL L 431 REMARK 465 LYS L 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET I 17 CG SD CE REMARK 470 ASN I 18 CG OD1 ND2 REMARK 470 MET I 20 CG SD CE REMARK 470 GLU I 27 CG CD OE1 OE2 REMARK 470 LYS I 28 CG CD CE NZ REMARK 470 ILE I 40 CG1 CG2 CD1 REMARK 470 GLU I 42 CG CD OE1 OE2 REMARK 470 ARG I 46 CG CD NE CZ NH1 NH2 REMARK 470 ARG I 47 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 133 CG CD CE NZ REMARK 470 ASN I 135 CG OD1 ND2 REMARK 470 LYS I 136 CG CD CE NZ REMARK 470 SER I 138 OG REMARK 470 LYS I 188 CG CD CE NZ REMARK 470 ARG I 235 NE CZ NH1 NH2 REMARK 470 LYS I 275 CD CE NZ REMARK 470 GLU I 357 CG CD OE1 OE2 REMARK 470 LYS L 11 CG CD CE NZ REMARK 470 ARG L 13 CG CD NE CZ NH1 NH2 REMARK 470 ARG L 24 CG CD NE CZ NH1 NH2 REMARK 470 ARG L 46 CD NE CZ NH1 NH2 REMARK 470 LYS L 107 CD CE NZ REMARK 470 GLU L 113 CG CD OE1 OE2 REMARK 470 LYS L 114 CG CD CE NZ REMARK 470 GLN L 118 CG CD OE1 NE2 REMARK 470 LYS L 125 CD CE NZ REMARK 470 ARG L 132 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 136 CG CD CE NZ REMARK 470 LYS L 139 CE NZ REMARK 470 LYS L 188 CE NZ REMARK 470 LYS L 193 CG CD CE NZ REMARK 470 GLU L 232 CD OE1 OE2 REMARK 470 ARG L 235 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 236 CE NZ REMARK 470 LYS L 287 CD CE NZ REMARK 470 GLU L 289 CG CD OE1 OE2 REMARK 470 LYS L 290 CG CD CE NZ REMARK 470 LYS L 297 CD CE NZ REMARK 470 ARG L 399 CG CD NE CZ NH1 NH2 REMARK 470 VAL L 400 CG1 CG2 REMARK 470 PHE L 402 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS L 403 CG CD CE NZ REMARK 470 ARG L 406 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO I 26 O SER I 112 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA I 134 N - CA - C ANGL. DEV. = 16.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE I 15 67.21 -115.09 REMARK 500 PRO I 19 -155.63 -56.97 REMARK 500 MET I 20 -11.67 66.73 REMARK 500 ASN I 96 -131.42 56.15 REMARK 500 LYS I 107 14.57 59.64 REMARK 500 SER I 112 -96.59 20.04 REMARK 500 GLU I 113 55.56 -144.65 REMARK 500 ALA I 134 -132.55 -150.54 REMARK 500 ASN I 135 139.31 144.90 REMARK 500 SER I 138 46.02 94.28 REMARK 500 ASP I 200 54.68 -144.76 REMARK 500 ARG I 261 128.89 176.56 REMARK 500 VAL I 263 -168.12 -111.84 REMARK 500 ALA I 264 134.87 -32.76 REMARK 500 ASP I 277 -26.92 72.49 REMARK 500 VAL I 341 -65.49 -100.14 REMARK 500 LEU I 351 70.64 -115.00 REMARK 500 PRO I 352 13.95 -68.11 REMARK 500 GLU I 357 109.67 -40.33 REMARK 500 ASP I 360 -83.85 -45.82 REMARK 500 SER I 380 76.53 -109.67 REMARK 500 ALA I 381 -159.18 -176.82 REMARK 500 ASN I 398 57.35 -112.58 REMARK 500 ASN I 418 45.51 38.39 REMARK 500 ASN I 428 103.03 -169.59 REMARK 500 ALA L 10 -178.08 -45.95 REMARK 500 PRO L 12 -77.56 -41.92 REMARK 500 ASP L 14 -75.72 -38.67 REMARK 500 PRO L 16 -82.95 -61.90 REMARK 500 MET L 17 108.28 38.13 REMARK 500 PRO L 19 -168.17 -55.32 REMARK 500 ASN L 96 -125.06 56.85 REMARK 500 ALA L 134 77.25 -113.90 REMARK 500 ASN L 135 137.90 133.59 REMARK 500 LYS L 136 -56.17 173.38 REMARK 500 SER L 137 -26.76 79.22 REMARK 500 GLU L 177 -71.05 -106.15 REMARK 500 ASP L 200 37.66 -146.26 REMARK 500 GLU L 205 -10.21 78.76 REMARK 500 GLU L 209 -8.99 -55.08 REMARK 500 GLN L 254 142.37 -172.14 REMARK 500 VAL L 263 -163.17 -117.79 REMARK 500 ALA L 264 -0.57 -12.33 REMARK 500 GLU L 265 34.51 169.47 REMARK 500 LYS L 275 107.31 -47.81 REMARK 500 ASP L 277 -9.11 83.40 REMARK 500 LYS L 290 -169.23 -75.50 REMARK 500 ALA L 293 -66.88 -14.10 REMARK 500 ALA L 356 -85.93 -20.33 REMARK 500 GLU L 357 34.21 -96.33 REMARK 500 REMARK 500 THIS ENTRY HAS 57 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR L 363 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E04 RELATED DB: PDB REMARK 900 RELATED ID: 1NQ9 RELATED DB: PDB DBREF 1OYH I 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1OYH L 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQADV 1OYH ALA I 137 UNP P01008 SER 169 ENGINEERED MUTATION SEQADV 1OYH ALA I 381 UNP P01008 GLU 413 ENGINEERED MUTATION SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS ALA SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER ALA ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS MODRES 1OYH ASN I 96 ASN GLYCOSYLATION SITE MODRES 1OYH ASN I 155 ASN GLYCOSYLATION SITE MODRES 1OYH ASN I 192 ASN GLYCOSYLATION SITE MODRES 1OYH ASN L 96 ASN GLYCOSYLATION SITE MODRES 1OYH ASN L 135 ASN GLYCOSYLATION SITE MODRES 1OYH ASN L 155 ASN GLYCOSYLATION SITE MODRES 1OYH ASN L 192 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET NAG I 801 14 HET NAG I 861 14 HET NAG L 801 14 HET NAG L 831 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 10(C8 H15 N O6) FORMUL 5 BMA C6 H12 O6 FORMUL 5 MAN 2(C6 H12 O6) FORMUL 10 HOH *54(H2 O) HELIX 1 1 LYS I 11 ILE I 15 5 5 HELIX 2 2 ASN I 45 SER I 69 1 25 HELIX 3 3 SER I 79 LYS I 91 1 13 HELIX 4 4 LEU I 92 ALA I 94 5 3 HELIX 5 5 CYS I 95 PHE I 106 1 12 HELIX 6 6 LYS I 107 ILE I 111 5 5 HELIX 7 7 THR I 115 LYS I 133 1 19 HELIX 8 8 ASN I 155 GLY I 167 1 13 HELIX 9 9 ASP I 174 THR I 194 1 21 HELIX 10 10 SER I 230 THR I 234 5 5 HELIX 11 11 ALA I 264 GLY I 266 5 3 HELIX 12 12 SER I 291 LEU I 299 1 9 HELIX 13 13 THR I 300 LEU I 311 1 12 HELIX 14 14 LEU I 331 ASP I 337 1 7 HELIX 15 15 VAL I 341 SER I 345 5 5 HELIX 16 16 PRO I 416 ASN I 418 5 3 HELIX 17 17 ALA L 43 ASP L 68 1 26 HELIX 18 18 SER L 79 LEU L 92 1 14 HELIX 19 19 CYS L 95 PHE L 106 1 12 HELIX 20 20 LYS L 107 ILE L 111 5 5 HELIX 21 21 THR L 115 ARG L 132 1 18 HELIX 22 22 ASN L 155 TYR L 166 1 12 HELIX 23 23 ASN L 178 THR L 194 1 17 HELIX 24 24 SER L 230 THR L 234 5 5 HELIX 25 25 SER L 291 LEU L 299 1 9 HELIX 26 26 THR L 300 LEU L 311 1 12 HELIX 27 27 LEU L 331 MET L 338 1 8 HELIX 28 28 VAL L 341 SER L 345 5 5 SHEET 1 A 4 VAL I 400 LYS I 403 0 SHEET 2 A 4 GLU I 312 PRO I 321 1 N HIS I 319 O PHE I 402 SHEET 3 A 4 SER I 246 VAL I 263 -1 N MET I 252 O MET I 320 SHEET 4 A 4 ARG I 235 TYR I 240 -1 N GLU I 237 O ALA I 249 SHEET 1 B 8 VAL I 400 LYS I 403 0 SHEET 2 B 8 GLU I 312 PRO I 321 1 N HIS I 319 O PHE I 402 SHEET 3 B 8 SER I 246 VAL I 263 -1 N MET I 252 O MET I 320 SHEET 4 B 8 THR I 267 PRO I 273 -1 O THR I 267 N VAL I 263 SHEET 5 B 8 ILE I 279 LEU I 285 -1 O MET I 281 N LEU I 272 SHEET 6 B 8 PHE I 408 GLU I 414 -1 O PHE I 411 N VAL I 282 SHEET 7 B 8 THR I 419 VAL I 426 -1 O GLY I 424 N VAL I 410 SHEET 8 B 8 ILE I 76 LEU I 78 -1 N ILE I 76 O ARG I 425 SHEET 1 C 5 LEU I 170 LEU I 173 0 SHEET 2 C 5 LEU I 140 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 C 5 LEU I 213 PHE I 221 -1 O VAL I 214 N PHE I 147 SHEET 4 C 5 ASP I 366 VAL I 375 1 O PHE I 368 N LEU I 215 SHEET 5 C 5 PHE I 323 SER I 330 -1 N ILE I 325 O LEU I 373 SHEET 1 D 2 LEU I 152 PHE I 154 0 SHEET 2 D 2 ILE I 354 ALA I 356 -1 O VAL I 355 N THR I 153 SHEET 1 E 2 GLY I 223 LEU I 224 0 SHEET 2 E 2 GLY I 379 SER I 380 -1 O SER I 380 N GLY I 223 SHEET 1 F 4 ALA I 387 ILE I 390 0 SHEET 2 F 4 GLU L 312 PRO L 321 1 O VAL L 317 N VAL I 389 SHEET 3 F 4 SER L 246 ARG L 262 -1 N GLN L 254 O VAL L 318 SHEET 4 F 4 ARG L 235 TYR L 240 -1 N ARG L 235 O MET L 251 SHEET 1 G 8 ALA I 387 ILE I 390 0 SHEET 2 G 8 GLU L 312 PRO L 321 1 O VAL L 317 N VAL I 389 SHEET 3 G 8 SER L 246 ARG L 262 -1 N GLN L 254 O VAL L 318 SHEET 4 G 8 GLN L 268 PRO L 273 -1 O VAL L 269 N ARG L 261 SHEET 5 G 8 ILE L 279 LEU L 285 -1 O MET L 281 N LEU L 272 SHEET 6 G 8 PHE L 408 GLU L 414 -1 O PHE L 411 N VAL L 282 SHEET 7 G 8 THR L 419 VAL L 426 -1 O PHE L 422 N ILE L 412 SHEET 8 G 8 ILE L 76 LEU L 78 -1 N ILE L 76 O ARG L 425 SHEET 1 H 5 PHE L 323 SER L 330 0 SHEET 2 H 5 VAL L 364 VAL L 375 -1 O VAL L 375 N PHE L 323 SHEET 3 H 5 GLY L 379 ILE L 390 -1 O ALA L 383 N PHE L 372 SHEET 4 H 5 LEU L 213 LEU L 224 -1 N LEU L 213 O ILE L 390 SHEET 5 H 5 LYS L 139 SER L 142 -1 N VAL L 141 O TYR L 220 SHEET 1 I 6 PHE L 323 SER L 330 0 SHEET 2 I 6 VAL L 364 VAL L 375 -1 O VAL L 375 N PHE L 323 SHEET 3 I 6 GLY L 379 ILE L 390 -1 O ALA L 383 N PHE L 372 SHEET 4 I 6 LEU L 213 LEU L 224 -1 N LEU L 213 O ILE L 390 SHEET 5 I 6 ARG L 145 ASP L 149 -1 N ARG L 145 O VAL L 216 SHEET 6 I 6 LYS L 169 LEU L 173 1 O GLN L 171 N LEU L 146 SSBOND 1 CYS I 8 CYS I 128 1555 1555 2.04 SSBOND 2 CYS I 21 CYS I 95 1555 1555 2.05 SSBOND 3 CYS I 247 CYS I 430 1555 1555 2.02 SSBOND 4 CYS L 8 CYS L 128 1555 1555 2.03 SSBOND 5 CYS L 21 CYS L 95 1555 1555 2.03 SSBOND 6 CYS L 247 CYS L 430 1555 1555 2.03 LINK ND2 ASN I 96 C1 NAG I 801 1555 1555 1.45 LINK ND2 ASN I 155 C1 NAG A 1 1555 1555 1.46 LINK ND2 ASN I 192 C1 NAG I 861 1555 1555 1.46 LINK ND2 ASN L 96 C1 NAG L 801 1555 1555 1.45 LINK ND2 ASN L 135 C1 NAG L 831 1555 1555 1.45 LINK ND2 ASN L 155 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN L 192 C1 NAG C 1 1555 1555 1.46 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.39 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.38 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.39 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.41 LINK O6 BMA C 3 C1 MAN C 5 1555 1555 1.40 CRYST1 68.998 98.573 89.350 90.00 105.53 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014493 0.000000 0.004027 0.00000 SCALE2 0.000000 0.010145 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011616 0.00000